AccessPak for HIV PEP Expanded with Viracept and Alemtuzumab (Lemtrada)
Determining the interaction of AccessPak for HIV PEP Expanded with Viracept and Alemtuzumab (Lemtrada) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / nelfinavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Viracept
Synonyms: n.a.
Generic Name: alemtuzumab
Brand name: Campath, Lemtrada
Synonyms: Alemtuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Viracept-Alemtuzumab Intravenous
- AccessPak for HIV PEP Expanded with Viracept-Alenaze-D
- AccessPak for HIV PEP Expanded with Viracept-Alendronate
- AccessPak for HIV PEP Expanded with Viracept-Alendronate and cholecalciferol
- AccessPak for HIV PEP Expanded with Viracept-Alendronate Effervescent Tablets
- AccessPak for HIV PEP Expanded with Viracept-Alendronate Oral Solution
- Alemtuzumab (Lemtrada)-Accolate
- Alemtuzumab (Lemtrada)-Accretropin
- Alemtuzumab (Lemtrada)-Accucaine
- Alemtuzumab (Lemtrada)-AccuHist Drops
- Alemtuzumab (Lemtrada)-AccuHist PDX Drops
- Alemtuzumab (Lemtrada)-AccuHist PDX Syrup